Xtant Medical Holdings, Inc. (XTNT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 50M 100M 150M Q3 '16: 87.8M Q4 '16: 90M Q1 '17: 91.1M Q2 '17: 91.1M Q3 '17: 87.8M Q4 '17: 82.6M Q1 '18: 78.5M Q2 '18: 75.8M Q3 '18: 73.3M Q4 '18: 72.2M Q1 '19: 71M Q2 '19: 67.5M Q3 '19: 66M Q4 '19: 64.7M Q1 '20: 62.7M Q2 '20: 58M Q3 '20: 56.3M Q4 '20: 53.3M Q1 '21: 51.1M Q2 '21: 55.5M Q3 '21: 55.3M Q4 '21: 55.3M Q1 '22: 55.7M Q2 '22: 56M Q3 '22: 56.7M Q4 '22: 58M Q1 '23: 63M Q2 '23: 67.9M Q3 '23: 78.5M Q4 '23: 91.3M Q1 '24: 101.2M Q2 '24: 110.9M Q3 '24: 113.9M Q4 '24: 117.3M Q1 '25: 122.3M Q2 '25: 127.8M Q3 '25: 133.1M Q4 '25: 133.9M Q1 '26: 121.9M Q2 '26: 109.5M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

0 30M 60M 90M Q3 '16: 59.7M Q4 '16: 62.3M Q1 '17: 63.1M Q2 '17: 61.9M Q3 '17: 57.3M Q4 '17: 50.1M Q1 '18: 47.4M Q2 '18: 46.4M Q3 '18: 46.5M Q4 '18: 43.5M Q1 '19: 42.1M Q2 '19: 39.5M Q3 '19: 38.4M Q4 '19: 42.5M Q1 '20: 41.3M Q2 '20: 38M Q3 '20: 36.8M Q4 '20: 34.4M Q1 '21: 32.9M Q2 '21: 35.8M Q3 '21: 33.8M Q4 '21: 32.5M Q1 '22: 32M Q2 '22: 30.8M Q3 '22: 31.5M Q4 '22: 32.1M Q1 '23: 35.1M Q2 '23: 39.2M Q3 '23: 46.6M Q4 '23: 55.5M Q1 '24: 62.2M Q2 '24: 68.4M Q3 '24: 69.3M Q4 '24: 68.2M Q1 '25: 71.2M Q2 '25: 76.9M Q3 '25: 82.5M Q4 '25: 84.3M Q1 '26: 76M Q2 '26: 65M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Income TTM

-75M -50M -25M 0 25M 50M 75M Q4 '15: -12.1M Q1 '16: -12.7M Q2 '16: -13.4M Q3 '16: -10.5M Q4 '16: -7.5M Q1 '17: -7.7M Q2 '17: -12M Q3 '17: -14.8M Q4 '17: -37.8M Q1 '18: -36.9M Q2 '18: -32.8M Q3 '18: -29.6M Q4 '18: -60.1M Q1 '19: -59.1M Q2 '19: -57.4M Q3 '19: -56.7M Q4 '19: -2.3M Q1 '20: -2.9M Q2 '20: -2.8M Q3 '20: -1.3M Q4 '20: -751K Q1 '21: 607K Q2 '21: 503K Q3 '21: -1.7M Q4 '21: -3.9M Q1 '22: -5.7M Q2 '22: -6.5M Q3 '22: -6.9M Q4 '22: -6.8M Q1 '23: -6.5M Q2 '23: -6.6M Q3 '23: -8.1M Q4 '23: -10.2M Q1 '24: -12.1M Q2 '24: -13.6M Q3 '24: -14M Q4 '24: -12.1M Q1 '25: -7.5M Q2 '25: 28K Q3 '25: 6.3M Q4 '16 Q1 '18 Q2 '19 Q3 '20 Q4 '21 Q1 '23 Q2 '24 Q3 '25

Net Income TTM

-75M -50M -25M 0 25M 50M 75M Q3 '16: -3.4M Q4 '16: -19.5M Q1 '17: -19.7M Q2 '17: -24.9M Q3 '17: -28.5M Q4 '17: -52.4M Q1 '18: -51.9M Q2 '18: -47.2M Q3 '18: -41.8M Q4 '18: -70.1M Q1 '19: -67.6M Q2 '19: -64.6M Q3 '19: -63.3M Q4 '19: -8.2M Q1 '20: -7.9M Q2 '20: -8.4M Q3 '20: -7.9M Q4 '20: -7M Q1 '21: -4.6M Q2 '21: -2.8M Q3 '21: -3.3M Q4 '21: -4.8M Q1 '22: -7M Q2 '22: -8M Q3 '22: -8.6M Q4 '22: -8.5M Q1 '23: -8.3M Q2 '23: -8.8M Q3 '23: 2.8M Q4 '23: 660K Q1 '24: -1.7M Q2 '24: -3.3M Q3 '24: -17.6M Q4 '24: -16.4M Q1 '25: -12M Q2 '25: -4.6M Q3 '25: 1.8M Q4 '25: 5M Q1 '26: 1.8M Q2 '26: -11.1M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

0 20M 40M 60M Q3 '16: 28.1M Q4 '16: 27.7M Q1 '17: 28M Q2 '17: 29.1M Q3 '17: 30.4M Q4 '17: 32.5M Q1 '18: 31M Q2 '18: 29.4M Q3 '18: 26.8M Q4 '18: 28.7M Q1 '19: 28.9M Q2 '19: 28M Q3 '19: 27.6M Q4 '19: 22.1M Q1 '20: 21.4M Q2 '20: 20M Q3 '20: 19.5M Q4 '20: 18.9M Q1 '21: 18.2M Q2 '21: 19.7M Q3 '21: 21.5M Q4 '21: 22.8M Q1 '22: 23.7M Q2 '22: 25.2M Q3 '22: 25.1M Q4 '22: 25.8M Q1 '23: 27.8M Q2 '23: 28.7M Q3 '23: 31.8M Q4 '23: 35.8M Q1 '24: 39M Q2 '24: 42.6M Q3 '24: 44.5M Q4 '24: 49.1M Q1 '25: 51.1M Q2 '25: 50.9M Q3 '25: 50.5M Q4 '25: 49.7M Q1 '26: 45.9M Q2 '26: 44.5M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow TTM

-18M -12M -6M 0 6M 12M 18M Q3 '15: -11.2M Q4 '15: -9.1M Q1 '16: -6M Q2 '16: -12.8M Q3 '16: -11.3M Q4 '16: -14.4M Q1 '17: -15M Q2 '17: -7.4M Q3 '17: -4.4M Q4 '17: -543K Q1 '18: -744K Q2 '18: 557K Q3 '18: -133K Q4 '18: 1.2M Q1 '19: 1.5M Q2 '19: 1.8M Q3 '19: 1.6M Q4 '19: -413K Q1 '20: -2.7M Q2 '20: -2.9M Q3 '20: -1.7M Q4 '21: 439K Q1 '22: 742K Q2 '22: -1.5M Q3 '22: -2.6M Q4 '22: -5.3M Q1 '23: -6.6M Q2 '23: -9.1M Q3 '23: -10.9M Q4 '23: -9.5M Q1 '24: -13M Q2 '24: -15.6M Q3 '24: -13.5M Q4 '24: -11.9M Q1 '25: -4.9M Q2 '25: 1.5M Q3 '25: 7.8M Q4 '25: 12.5M Q1 '26: 9.2M Q2 '26: 570K Q3 '16 Q4 '17 Q1 '19 Q2 '20 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

-21M -14M -7M 0 7M 14M 21M Q3 '15: -11.7M Q4 '15: -11.4M Q1 '16: -10.9M Q2 '16: -19.3M Q3 '16: -18.7M Q4 '16: -20.2M Q1 '17: -18.4M Q2 '17: -9.9M Q3 '17: -6.1M Q4 '17: -2.2M Q1 '18: -2.2M Q2 '18: -304K Q3 '18: -626K Q4 '18: 588K Q1 '19: 837K Q2 '19: 1.3M Q3 '19: 930K Q4 '19: -1.3M Q1 '20: -3.7M Q2 '20: -4.3M Q3 '20: -3.1M Q4 '21: -1.7M Q1 '22: -1.3M Q2 '22: -3.3M Q3 '22: -4.6M Q4 '22: -7.1M Q1 '23: -8.3M Q2 '23: -10.9M Q3 '23: -12.4M Q4 '23: -11M Q1 '24: -14.8M Q2 '24: -17.5M Q3 '24: -17.3M Q4 '24: -16M Q1 '25: -9.4M Q2 '25: -2.8M Q3 '25: 5.2M Q4 '25: 10.2M Q1 '26: 7.8M Q2 '26: -696K Q3 '16 Q4 '17 Q1 '19 Q2 '20 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 60M 120M 180M Q2 '13: 4.5M Q3 '13: 5.2M Q1 '14: 5.4M Q2 '14: 5.5M Q3 '14: 6.2M Q1 '15: 6.7M Q2 '15: 7.1M Q3 '15: 10.4M Q1 '16: 11.9M Q2 '16: 12.1M Q3 '16: 12.2M Q1 '17: 1.5M Q2 '17: 1.5M Q3 '17: 1.5M Q1 '18: 7.5M Q2 '18: 13.1M Q3 '18: 13.2M Q1 '19: 13.2M Q2 '19: 13.2M Q3 '19: 13.2M Q1 '20: 13.2M Q2 '20: 13.2M Q3 '20: 13.2M Q1 '21: 81.2M Q2 '21: 86.7M Q3 '21: 86.8M Q1 '22: 87.2M Q2 '22: 87.3M Q3 '22: 93.3M Q1 '23: 108.9M Q2 '23: 108.9M Q3 '23: 135.7M Q1 '24: 130.2M Q2 '24: 130.3M Q3 '24: 135.1M Q1 '25: 143.3M Q2 '25: 148.6M Q3 '25: 150.4M Q1 '26: 140.1M Q2 '26: 140.3M Q3 '14 Q2 '16 Q1 '18 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-45.00 -30.00 -15.00 0.00 15.00 30.00 45.00 Q3 '16: 0.19 Q4 '16: -18.46 Q1 '17: -21.86 Q2 '17: -27.92 Q3 '17: -33.14 Q4 '17: -34.74 Q1 '18: -31.57 Q2 '18: -25.52 Q3 '18: -20.14 Q4 '18: -6.10 Q1 '19: -5.61 Q2 '19: -5.38 Q3 '19: -5.28 Q4 '19: -0.63 Q1 '20: -0.61 Q2 '20: -0.65 Q3 '20: -0.61 Q4 '20: -0.25 Q1 '21: -0.06 Q2 '21: 0.12 Q3 '21: 0.20 Q4 '21: -0.06 Q1 '22: -0.09 Q2 '22: -0.10 Q3 '22: -0.11 Q4 '22: -0.10 Q1 '23: -0.09 Q2 '23: -0.09 Q3 '23: 0.01 Q4 '23: 0.01 Q1 '24: 0.00 Q2 '24: -0.01 Q3 '24: -0.12 Q4 '24: -0.12 Q1 '25: -0.09 Q2 '25: -0.04 Q3 '25: 0.01 Q4 '25: 0.03 Q1 '26: 0.01 Q2 '26: -0.08 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.